These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 15157565)
21. Sepsis and those who are "weak of heart". van Kimmenade RR; Bajwa E; Januzzi JL Crit Care Med; 2008 Nov; 36(11):3108-9. PubMed ID: 18941317 [No Abstract] [Full Text] [Related]
22. Biomarkers in heart failure. Braunwald E N Engl J Med; 2008 May; 358(20):2148-59. PubMed ID: 18480207 [No Abstract] [Full Text] [Related]
23. [Natriuretic peptides in heart failure]. Emdin M; Poletti R; Giannoni A; Mazzei MG; Mammini C; Gabutti A; Agazio A; Caprioli R; Passino C G Ital Nefrol; 2006; 23 Suppl 34():S32-7. PubMed ID: 16633992 [TBL] [Abstract][Full Text] [Related]
24. Cardiovascular and metabolic effects of natriuretic peptides. Moro C; Berlan M Fundam Clin Pharmacol; 2006 Feb; 20(1):41-9. PubMed ID: 16448393 [TBL] [Abstract][Full Text] [Related]
26. Natriuretic peptide-guided management of patients with heart failure: a decade of progress but still a controversy. Baibars M; Ibrahim A; Fang JC; Sipahi I Future Cardiol; 2010 Nov; 6(6):743-7. PubMed ID: 21142628 [No Abstract] [Full Text] [Related]
27. Effects of levosimendan on right ventricular function in patients with advanced heart failure. Parissis JT; Paraskevaidis I; Bistola V; Farmakis D; Panou F; Kourea K; Nikolaou M; Filippatos G; Kremastinos D Am J Cardiol; 2006 Dec; 98(11):1489-92. PubMed ID: 17126656 [TBL] [Abstract][Full Text] [Related]
28. Natriuretic peptides and heart failure in the patient with chronic kidney disease: a review of current evidence. Dhar S; Pressman GS; Subramanian S; Kaul S; Gollamudi S; Bloom EJ; Figueredo VM Postgrad Med J; 2009 Jun; 85(1004):299-302. PubMed ID: 19528304 [TBL] [Abstract][Full Text] [Related]